Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins

Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins

Background For effective tumor elimination, cytotoxic CD8+ T cells must recognize tumor-derived antigens presented on class I major histocompatibility complex (MHC-I). Despite a general association between the expression of immunogenic antigens, typically neoantigens, and response to immunotherapy,...

Full description

Bibliographic Details
Main Authors:	Stefani Spranger, Fiona Chatterjee, Esmee P Hoefsmit, Tim B Fessenden, Lauren E Stopfer, Julian Zulueta, Josh Mesfin, Therese Cordero Dumit, Irene Reijers, Christian Blank, Forest White
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/10/7/e004159.full

Similar Items

Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins
by: Fessenden, Tim B, et al.
Published: (2023)

538 Harnessing cross-dressing dendritic cells to strengthen anti-tumor immunity
by: Stefani Spranger, et al.
Published: (2020-11-01)

947 The activation states of tumor-resident type 2 dendritic cells impact the strength of ovarian cancer immune responses
by: Stefani Spranger, et al.
Published: (2023-11-01)

A team effort: natural killer cells on the first leg of the tumor immunity relay race
by: Timothy B. Fessenden, et al.
Published: (2018-07-01)

A team effort: natural killer cells on the first leg of the tumor immunity relay race
by: Fessenden, Timothy B, et al.
Published: (2018)

Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition
by: Stopfer, Lauren E, et al.
Published: (2021)

Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition
by: Stopfer, Lauren E, et al.
Published: (2022)

Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition
by: Lauren E. Stopfer, et al.
Published: (2020-06-01)

766 Toward safe, systemic delivery of synthetic TLR7/8 agonists using Bottlebrush Prodrugs (BPDs)
by: Bin Liu, et al.
Published: (2021-11-01)

Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events
by: Esmée P. Hoefsmit, et al.
Published: (2019-07-01)

Quantitative Consequences of Protein Carriers in Immunopeptidomics and Tyrosine Phosphorylation MS2 Analyses
by: Stopfer, Lauren Elizabeth, et al.
Published: (2022)

Quantitative Consequences of Protein Carriers in Immunopeptidomics and Tyrosine Phosphorylation MS2 Analyses
by: Stopfer, Lauren E, et al.
Published: (2021)

NOD/scid IL-2Rg<sup>null </sup>mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies <it>in vivo</it>
by: Spranger Stefani, et al.
Published: (2012-02-01)

929 Mutual interactions between neoantigen-specific CD8+ T cell responses facilitate immune evasion in sub-clonal tumors
by: Stefani Spranger, et al.
Published: (2023-11-01)

Impact of oncogenic pathways on evasion of antitumour immune responses
by: Spranger, Stefani
Published: (2020)

WNT Signaling in Cancer Immunosurveillance
by: Spranger, Stefani
Published: (2020)

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
by: Spranger, Stefani
Published: (2020)

MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas
by: Stopfer, Lauren E, et al.
Published: (2023)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)
by: Spranger-Zimmermann, Stefani
Published: (2020)

Quantitative mass spectrometry-based approaches for characterizing the immunopeptidome and tyrosine phosphoproteome in cancer
by: Stopfer, Lauren Elizabeth
Published: (2022)

High-density, targeted monitoring of tyrosine phosphorylation reveals activated signaling networks in human tumors
by: Stopfer, Lauren E, et al.
Published: (2021)

A Tumor Cell-Intrinsic Yin-Yang Determining Immune Evasion
by: Horton, Brendan, et al.
Published: (2020)

Microtubule-Based Control of Motor-Clutch System Mechanics in Glioma Cell Migration
by: Prahl, Louis S., et al.
Published: (2020)

Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
by: Nguyen, Kim Bich, et al.
Published: (2021)

Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants
by: Stopfer, Lauren E, et al.
Published: (2023)

Impact of anatomic site on antigen-presenting cells in cancer
by: Zagorulya, Maria, et al.
Published: (2023)

How to Make the Perfect Citizen?
by: Wessel Reijers

Dendritic Cells Activate and Mature after Infection with <it>Mycobacterium tuberculosis</it>
by: Mamo Gezahagne, et al.
Published: (2011-07-01)

The safe care and handling of gases [slaid]/
by: Fessenden, Ralph J., et al.
Published: (1975)

Coping with fires and runaway reactions / [slaid]
by: Fessenden, Ralph J., et al.
Published: (1975)

A Look at the laboratory [slaid]/
by: Fessenden, Ralph J., et al.
Published: (1975)

A Flask for the task [slaid]/
by: Fessenden, Ralph J., et al.
Published: (1975)

Boiling and distilling [slaid]/
by: Fessenden, Ralph J., et al.
Published: (1975)

The Separatory funnel [slaid]/
by: Fessenden, Ralph J., et al.
Published: (1975)

Continous extraction [slaid]/
by: Fessenden, Ralph J., et al.
Published: (1975)

The Three-necked flask [slaid]/
by: Fessenden, Ralph J., et al.
Published: (1975)

Separation of plasmacytoid dendritic cells from B-cell-biased lymphoid progenitor (BLP) and Pre-pro B cells using PDCA-1.
by: Kay L Medina, et al.
Published: (2013-01-01)

1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs
by: Stopfer, LE, et al.
Published: (2023)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
by: Kim Bich Nguyen, et al.
Published: (2023-08-01)

The Chemokine Receptor CCR7 Uses Distinct Signaling Modules With Biased Functionality to Regulate Dendritic Cells
by: José Luis Rodríguez-Fernández, et al.
Published: (2020-04-01)